| S-1 | 2020-07-13 | Public Filing |
| 10-Q | 2020-06-30 | Filed 2020-08-13 |
| 10-Q | 2020-03-31 | Filed 2020-05-08 |
| 10-K | 2019-12-31 | Filed 2020-03-23 |
| 10-Q | 2019-09-30 | Filed 2019-11-14 |
| 10-Q | 2019-06-30 | Filed 2019-08-09 |
| S-1 | 2019-06-04 | Public Filing |
| 10-Q | 2019-03-31 | Filed 2019-05-10 |
| 10-K | 2018-12-31 | Filed 2019-03-14 |
| 10-Q | 2018-09-30 | Filed 2018-11-14 |
| 10-Q | 2018-06-30 | Filed 2018-08-10 |
| 10-Q | 2018-03-31 | Filed 2018-05-15 |
| S-1 | 2018-03-23 | Public Filing |
| 10-K | 2017-12-31 | Filed 2018-03-19 |
| 10-Q | 2017-09-30 | Filed 2017-11-14 |
| 10-Q | 2017-06-30 | Filed 2017-08-11 |
| 10-Q | 2017-03-31 | Filed 2017-05-12 |
| 10-K | 2016-12-31 | Filed 2017-03-10 |
| 10-Q | 2016-09-30 | Filed 2016-11-09 |
| 10-Q | 2016-06-30 | Filed 2016-08-12 |
| 10-Q | 2016-03-31 | Filed 2016-05-13 |
| 10-K | 2015-12-31 | Filed 2016-03-21 |
| 10-Q | 2015-09-30 | Filed 2015-11-12 |
| 10-Q | 2015-06-30 | Filed 2015-08-14 |
| 10-Q | 2015-03-31 | Filed 2015-05-13 |
| 10-K | 2014-12-31 | Filed 2015-03-27 |
| 10-Q | 2014-09-30 | Filed 2014-11-14 |
| 10-Q | 2014-06-30 | Filed 2014-09-15 |
| 10-Q | 2014-04-30 | Filed 2014-06-05 |
| 10-Q | 2014-01-31 | Filed 2014-03-17 |
| 10-K | 2013-10-31 | Filed 2014-01-27 |
| 10-Q | 2013-07-31 | Filed 2013-09-16 |
| 10-Q | 2013-04-30 | Filed 2013-06-27 |
| 8-K | 2020-08-07 | Officers, Other Events, Exhibits |
| 8-K | 2020-07-31 | Enter Agreement, Other Events, Exhibits |
| 8-K | 2020-06-17 | |
| 8-K | 2020-04-29 | |
| 8-K | 2019-12-17 | |
| 8-K | 2019-11-21 | |
| 8-K | 2019-11-19 | |
| 8-K | 2019-08-23 | |
| 8-K | 2019-08-21 | |
| 8-K | 2019-08-07 | |
| 8-K | 2019-05-24 | |
| 8-K | 2019-03-29 | |
| 8-K | 2019-03-25 | |
| 8-K | 2019-02-26 | |
| 8-K | 2019-02-01 | |
| 8-K | 2018-11-14 | |
| 8-K | 2018-11-01 | |
| 8-K | 2018-10-05 | |
| 8-K | 2018-07-31 | |
| 8-K | 2018-06-01 | |
| 8-K | 2018-04-30 | |
| 8-K | 2018-02-16 | |
| 8-K | 2018-02-13 | |
| 8-K | 2018-01-19 | |
| 8-K | 2017-12-28 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Portage Biotech (PTGEF) | 119,437 | 0% | 173,715 | 25,158 | 0 | 0 | 0 | 0 | 113,271 | ||
| Nuzee (NUZE) | 117,875 | 16% | -10.0 | -232% | 5,251 | 1,135 | 1,794 | 295 | -12,176 | -11,718 | 116,706 |
| Invesco DB Base Metals Fund (DBB) | 117,360 | -27.0 | -3% | 129,674 | 11,075 | 0 | 0 | -4,521 | -4,348 | 117,360 | |
| Security Federal (SFDL) | 111,925 | 5.4 | 1% | 991,261 | 898,959 | 0 | 0 | 7,742 | 18,302 | 98,131 | |
| ATIF Holdings (ATIF) | 110,483 | 0% | 12,343 | 1,141 | 0 | 0 | 0 | 0 | 104,023 | ||
| Sears Holdings (SHLD) | 110,090 | 19% | -3.7 | -5% | 33,110,000 | 35,625,000 | 13,191,000 | 2,568,000 | -1,700,000 | -611,000 | 2,291,090 |
| CSB Bancorp (CSBB) | 109,694 | 2.0 | 1% | 786,792 | 703,178 | 0 | 0 | 10,313 | 15,275 | 30,125 | |
| Nemus Bioscience (NMUS) | 108,999 | -34.9 | -220% | 1,725 | 18,127 | 0 | 0 | -3,800 | -3,087 | 107,675 | |
| Eagle Financial Services (EFSI) | 108,359 | 5.2 | 1% | 851,419 | 756,789 | 0 | 0 | 9,009 | 13,416 | 69,203 | |
| UTG (UTGN) | 106,601 | 0% | 4.4 | 3% | 418,871 | 289,863 | 35,179 | 0 | 13,535 | 18,338 | 80,872 |
| Consumer Capital Group (CCGN) | 106,115 | 100% | -60.0 | -140% | 1,266 | 7,930 | 228 | 228 | -1,772 | -1,767 | 106,047 |
| Bay Banks of Virginia (BAYK) | 104,674 | 3.9 | 0% | 1,112,219 | 987,362 | 0 | 0 | 5,056 | 18,746 | 73,361 | |
| Epsilon Energy (EPSN) | 103,584 | 0% | 8.7 | 7% | 95,010 | 19,649 | 11,983 | 0 | 6,665 | 9,734 | 84,837 |
| Juniata Valley Financial (JUVF) | 102,429 | 13.6 | 1% | 667,107 | 593,321 | 0 | 0 | 5,568 | 9,850 | 134,126 | |
| F&M Bank (FMBM) | 102,135 | 16.1 | 0% | 813,237 | 722,344 | 0 | 0 | 2,734 | 8,653 | 139,285 | |
| Invesco CurrencyShares Australian Dollar Trust (FXA) | 100,780 | 0% | -56.1 | 1% | 97,821 | 32 | 1,223 | 0 | 788 | 788 | -44,220 |
| Zoned Properties (ZDPY) | 100,699 | 0% | 277.2 | 0% | 8,204 | 2,225 | 941 | 0 | 7 | 368 | 102,125 |
| Virginia National Bankshares (VABK) | 99,658 | 7.1 | 1% | 660,790 | 585,236 | 0 | 0 | 5,258 | 10,047 | 71,803 | |
| Juniper Pharmaceuticals (JNP) | 98,834 | 41% | 49.7 | -1% | 67,768 | 19,275 | 55,610 | 22,712 | -985 | 1,629 | 80,918 |
| Hash Labs (HLAB) | 98,593 | -24.3 | -2,247% | 181 | 419 | 0 | 0 | -4,067 | -4,048 | 98,439 |
| Balance Sheet ($'000) | 2013-04-30 | 2013-07-31 | 2013-10-31 | 2014-01-31 | 2014-04-30 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash | 30 | 37 | 52 | 46 | 50 | 39 | 1,025 | 207 | 177 | 601 | 4,343 | 3,221 | 2,062 | 832 | 320 | 65 | 380 | 109 | 42 | 260 | 2,950 | 1,879 | 1,063 | 1,858 | 4,417 | 2,812 | 1,324 |
| Accounts Receivable | 32 | 29 | 25 | 35 | 35 | 27 | |||||||||||||||||||||
| Inventory | |||||||||||||||||||||||||||
| PP&E | 69 | 47 | 47 | 47 | 47 | 96 | 12 | 21 | 19 | 17 | 16 | 13 | 21 | 17 | 13 | 10 | 7 | 5 | 3 | 1 | 2 | 5 | 4 | 3 | 3 | 3 | 2 |
| Assets | 134 | 129 | 146 | 141 | 123 | 168 | 1,126 | 348 | 469 | 821 | 4,542 | 3,511 | 2,350 | 1,081 | 692 | 323 | 617 | 484 | 343 | 557 | 3,158 | 2,042 | 1,166 | 1,957 | 4,725 | 3,080 | 1,725 |
| Accounts Payable | 409 | 388 | 286 | 132 | 125 | 137 | 183 | 387 | 275 | 227 | 679 | 990 | 101 | 99 | 12 | 46 | 16 | 168 | 73 | 207 | |||||||
| Long-Term Debt | 43 | ||||||||||||||||||||||||||
| Liabilities | 69 | 64 | 62 | 54 | 49 | 86 | 350 | 802 | 807 | 1,682 | 3,515 | 3,040 | 3,360 | 1,337 | 1,711 | 1,774 | 1,847 | 2,262 | 2,448 | 1,357 | 8,912 | 10,288 | 11,321 | 17,519 | 32,589 | 14,721 | 18,127 |
| Stockholders' Equity | 66 | 65 | 83 | 87 | 73 | 81 | 776 | -454 | -338 | -861 | -594 | -892 | -2,370 | -1,615 | -2,379 | -2,914 | -2,879 | -2,927 | -3,230 | -3,570 | -5,754 | -8,245 | -10,155 | -15,562 | -27,864 | -11,641 | -16,402 |
| Income Statement ($'000) | 2013-04-30 | 2013-07-31 | 2013-10-31 | 2014-01-31 | 2014-04-30 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Revenue | |||||||||||||||||||||||||||
| Cost of Revenue | |||||||||||||||||||||||||||
| Gross Profit | |||||||||||||||||||||||||||
| R&D | 195 | 32 | 37 | 43 | 152 | 343 | 135 | 460 | 81 | 263 | 92 | 61 | 89 | 70 | 25 | -64 | 67 | 321 | 688 | 513 | |||||||
| SG&A | 4 | 5 | 16 | 9 | 7 | 9 | 663 | 466 | 873 | 1,313 | 744 | 811 | 1,085 | 1,022 | 776 | 649 | 1,288 | 670 | 673 | 917 | 1,226 | 1,080 | 978 | 1,194 | 1,083 | 990 | |
| Tax | 1 | -1 | -0 | 0 | 1 | 0 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | -2 | 0 | 2 | 0 | 0 | 2 | 0 | ||
| Net Income | 2 | -1 | -5 | 4 | -14 | 8 | -859 | -2,732 | -910 | -2,057 | -1,183 | -691 | -1,685 | 573 | -945 | -1,120 | -1,283 | -703 | -480 | -628 | -8,214 | -2,662 | -2,096 | -14,774 | 15,905 | -4,931 | |
| Cash Flow ($'000) | 2013-04-30 | 2013-07-31 | 2013-10-31 | 2014-01-31 | 2014-04-30 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash Operating | 7 | -8 | -4 | 3 | 8 | -952 | -1,762 | -752 | -568 | -1,295 | -1,114 | -1,148 | -1,230 | -512 | -663 | -816 | -271 | -67 | -2,144 | -1,053 | -816 | -1,431 | -1,605 | -1,488 | |||
| Cash Investing | 5 | 22 | 45 | 0 | 0 | -2 | 0 | -11 | 0 | 0 | -1 | 0 | |||||||||||||||
| Cash Financing | -4 | 1 | -2 | 0 | 49 | 1,991 | 1,938 | 721 | 992 | 5,038 | -8 | 408 | 1,132 | 0 | 0 | 2,381 | 3,740 | 0 | 3,991 | 0 | 0 | ||||||